JSP Unveils 6 Strategies for 300 Billion Baht Pharma Market, Eyes Profit Growth with 'Suphap Osot' Brand
Thai pharmaceutical giant JSP has announced six strategies to capture the domestic pharmaceutical market, valued at 300 billion baht. The company aims to expand its profitability by strengthening the 'Suphap Osot' brand.
This article requires PRO
This article is outside the free access window or is a special report. PRO unlocks it and the full archive.
Related articles
- Thai Pet Food Market Shows Strong Growth Aligned with PETOUR's Domestic Production Plans
Thailand's pet food market is demonstrating robust growth, coinciding with PETOUR's plans to establish domestic production facilities. The company aims to expand its production capacity within Thailand to meet market expansion.
- Luxury Home Robbery in Chonburi, Thailand, Targets Cash, Rolex, and Cryptocurrency
A luxury home in Nong Phrue, Chonburi, Thailand, was targeted by three robbers who stole cash, Rolex watches, and forced a cryptocurrency transfer, with estimated damages nearing 30 million baht.
- One Bangkok Marks 2nd Anniversary with Brand Refresh and Enhanced Experiences
One Bangkok, a major mixed-use development in central Bangkok, celebrates its second anniversary. The project aims for further growth by introducing new brands and experiences, marking it as a significant urban development initiative in Thailand.
- Thai Senate Debates UPOV 1991, Raising Concerns Over Agricultural Costs and Rising Medicine Prices
The Thai Senate debated the accession to the UPOV 1991 convention during the ongoing EU-Thailand Free Trade Agreement (FTA) negotiations. Senators expressed strong concerns regarding potential increases in agricultural costs, rising seed prices, and the impact on public access to medicines.